CORT · Forms 3, 4, 5
Insider trades at CORCEPT THERAPEUTICS INC
4 insiders sold $6.2M of CORCEPT THERAPEUTICS INC stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for CORCEPT THERAPEUTICS INC (CORT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| James N Wilson | Director | Sell | 6,654 | $114.48 | $762K | Form 4 | |
| James N Wilson | Director | Sell | 3,046 | $115.39 | $351K | Form 4 | |
| James N Wilson | Director | Sell | 300 | $116.30 | $35K | Form 4 | |
| Justin Frederick Gunn | See Remarks | Options or other derivatives | Form 4 | ||||
| Justin Frederick Gunn | See Remarks | Became an insider (Form 3) | Form 3 | ||||
| Roberto Wandenkolk Vieira | President, Oncology | Option exercise | 8,333 | $21.63 | $180K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 1,100 | $114.52 | $126K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 2,086 | $115.73 | $241K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 5,147 | $116.59 | $600K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Option exercise | 3,357 | $13.56 | $46K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Option exercise | 5,833 | $19.26 | $112K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 4,446 | $115.70 | $514K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 4,744 | $116.54 | $553K | Form 4 | |
| Sean Maduck | See Remarks | Option exercise | 24,587 | $8.27 | $203K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 15,843 | $116.12 | $1.8M | Form 4 | |
| Sean Maduck | See Remarks | Sell | 8,744 | $116.55 | $1M | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Option exercise | 810 | $13.56 | $11K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 810 | $115.40 | $93K | Form 4 | |
| Sean Maduck | See Remarks | Option exercise | 413 | $8.27 | $3K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 413 | $115.54 | $48K | Form 4 | |
| Gary Charles Robb | Chief Business Officer | Gift | 17,100 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Gift | 5,000 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Gift | 5,000 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Option exercise | 17,493 | $8.27 | $145K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 296 | $100.82 | $30K | Form 4 | |
| James N Wilson | Director | Sell | 6,800 | $110.27 | $750K | Form 4 | |
| James N Wilson | Director | Sell | 400 | $110.84 | $44K | Form 4 | |
| James N Wilson | Director | Sell | 2,800 | $111.70 | $313K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Option exercise | 2,596 | $11.35 | $29K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Option exercise | 7,404 | $13.56 | $100K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 7,812 | $113.32 | $885K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 2,188 | $114.12 | $250K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Became an insider (Form 3) | Form 3 | ||||
| Sean Maduck | See Remarks | Tax withholding | 117 | $113.38 | $13K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Tax withholding | 102 | $113.38 | $12K | Form 4 | |
| Gary Charles Robb | Chief Business Officer | Tax withholding | 91 | $113.38 | $10K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Tax withholding | 102 | $113.38 | $12K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Option exercise | 58,333 | $21.63 | $1.3M | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 23,600 | $109.35 | $2.6M | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 23,770 | $110.70 | $2.6M | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 1,537 | $111.37 | $171K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 974 | $112.40 | $109K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 1,606 | $113.72 | $183K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 5,621 | $114.58 | $644K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Sell | 1,225 | $115.44 | $141K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Tax withholding | 72 | $113.38 | $8K | Form 4 | |
| William Guyer | Chief Development Officer | Award | 164 | $113.38 | $19K | Form 4 | |
| William Guyer | Chief Development Officer | Award | 164 | Form 4 | |||
| Sean Maduck | See Remarks | Option exercise | 25,000 | $8.27 | $207K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 11,730 | $113.94 | $1.3M | Form 4 | |
| Sean Maduck | See Remarks | Sell | 10,989 | $114.71 | $1.3M | Form 4 | |
| Sean Maduck | See Remarks | Sell | 2,281 | $115.61 | $264K | Form 4 | |
| Sean Maduck | See Remarks | Award | 150 | $113.38 | $17K | Form 4 | |
| Sean Maduck | See Remarks | Award | 150 | Form 4 | |||
| Atabak Mokari | Chief Financial Officer | Award | 138 | $113.38 | $16K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Award | 138 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Award | 164 | $113.38 | $19K | Form 4 | |
| Gary Charles Robb | Chief Business Officer | Award | 164 | Form 4 | |||
| Roberto Wandenkolk Vieira | President, Oncology | Award | 138 | $113.38 | $16K | Form 4 | |
| Roberto Wandenkolk Vieira | President, Oncology | Award | 138 | Form 4 | |||
| Joseph Douglas Lyon | See Remarks | Award | 130 | $113.38 | $15K | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Award | 130 | Form 4 | |||
| Kimberly Park | Director | Option exercise | 30,000 | $13.49 | $405K | Form 4 | |
| Kimberly Park | Director | Tax withholding | 3,315 | $122.09 | $405K | Form 4 | |
| Kimberly Park | Director | Sell | 26,685 | $122.55 | $3.3M | Form 4 | |
| Sean Maduck | See Remarks | Option exercise | 30,955 | $11.35 | $351K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 25,085 | $125.47 | $3.1M | Form 4 | |
| Sean Maduck | See Remarks | Sell | 5,870 | $126.06 | $740K | Form 4 | |
| David L Mahoney | Director | Sell | 4,984 | $117.47 | $585K | Form 4 | |
| David L Mahoney | Director | Sell | 91,167 | $118.24 | $10.8M | Form 4 | |
| David L Mahoney | Director | Sell | 7,055 | $118.88 | $839K | Form 4 | |
| David L Mahoney | Director | Sell | 400 | $119.64 | $48K | Form 4 | |
| Gary Charles Robb | Chief Business Officer | Gift | 125 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Sell | 10,000 | $116.26 | $1.2M | Form 4 | |
| Sean Maduck | See Remarks | Option exercise | 3,664 | $8.27 | $30K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 3,664 | $114.49 | $419K | Form 4 | |
| James N Wilson | Director | Sell | 3,053 | $110.49 | $337K | Form 4 | |
| James N Wilson | Director | Sell | 4,668 | $111.44 | $520K | Form 4 | |
| James N Wilson | Director | Sell | 2,279 | $112.64 | $257K | Form 4 | |
| Gary Charles Robb | Chief Business Officer | Gift | 11,530 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Gift | 3,000 | Form 4 | |||
| Gary Charles Robb | Chief Business Officer | Gift | 3,000 | Form 4 | |||
| Sean Maduck | See Remarks | Option exercise | 1,031 | $8.27 | $9K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 1,031 | $114.52 | $118K | Form 4 | |
| William Guyer | Chief Development Officer | Option exercise | 16,300 | $21.65 | $353K | Form 4 | |
| William Guyer | Chief Development Officer | Sell | 11,530 | $113.18 | $1.3M | Form 4 | |
| William Guyer | Chief Development Officer | Sell | 4,770 | $114.04 | $544K | Form 4 | |
| William Guyer | Chief Development Officer | Option exercise | 3,700 | $21.65 | $80K | Form 4 | |
| William Guyer | Chief Development Officer | Sell | 3,700 | $113.12 | $419K | Form 4 | |
| Sean Maduck | See Remarks | Option exercise | 20,305 | $8.27 | $168K | Form 4 | |
| Sean Maduck | See Remarks | Sell | 20,305 | $114.70 | $2.3M | Form 4 | |
| Joseph Douglas Lyon | See Remarks | Sell | 1,540 | $114.16 | $176K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Option exercise | 80,000 | $23.06 | $1.8M | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 4,200 | $105.54 | $443K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 8,956 | $106.96 | $958K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 400 | $108.46 | $43K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 2,202 | $110.03 | $242K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 600 | $110.95 | $67K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 4,700 | $113.18 | $532K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 15,477 | $114.96 | $1.8M | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 14,222 | $115.87 | $1.6M | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 7,089 | $116.96 | $829K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 8,267 | $117.93 | $975K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 4,783 | $118.73 | $568K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 8,103 | $119.95 | $972K | Form 4 | |
| Atabak Mokari | Chief Financial Officer | Sell | 1,001 | $120.67 | $121K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.